Research Article
Cystatin C Is an Important Biomarker for Cardiovascular Autonomic Dysfunction in Chinese Type 2 Diabetic Patients
Table 1
Characteristics of patients with type 2 diabetes according to serum cystatin C tertiles.
| | Tertile 1 (<0.78) | Tertile 2 (0.78–0.99) | Tertile 3 (>0.99) | Total | value | Tertile 1 vs. 2 | Tertile 1 vs. 3 | Tertile 2 vs. 3 |
| | 52 | 57 | 52 | 161 | | | | Men (%) | 21 (40) | 22 (29) | 18 (35) | 61 (38) | | | | Age (years) | | | | | <0.01 | <0.01 | <0.01 | Diabetes duration (years) | | | | | 0.08 | <0.01 | <0.01 | BMI (kg/m2) | | | | | 0.07 | 0.24 | 0.53 | SBP (mmHg) | | | | | 0.96 | 0.96 | 0.91 | DBP (mmHg) | | | | | 0.08 | 0.01 | 0.39 | HbA1c (%) | | | | | 0.36 | 0.11 | 0.47 | TC (mmol/l) | | | | | 0.80 | 0.40 | 0.54 | TG (mmol/l) | | | | | 0.93 | 0.17 | 0.13 | HDL-C (mmol/l) | | | | | 0.66 | 0.30 | 0.13 | LDL-C (mmol/l) | | | | | 0.89 | 0.45 | 0.51 | B2-MG (μg/l) | | | | | 0.22 | 0.69 | 0.42 | Cr (μmol/l) | | | | | 0.07 | <0.01 | <0.01 | eGFR (ml/min/1.73 m2) | | | | | <0.01 | <0.01 | <0.01 | FBG (mmol/l) | | | | | 0.33 | 0.02 | 0.18 | UA (μmol/l) | | | | | 0.48 | <0.01 | <0.01 | SDNN (ms) | | | | | 0.51 | <0.01 | <0.01 | SDANN (ms) | | | | | 0.56 | <0.01 | <0.01 | LogRMSSD (ms) | | | | | 0.40 | 0.92 | 0.45 | LogPNN50 (%) | | | | | 0.55 | 0.25 | 0.55 | LogLF (ms2) | | | | | 0.60 | 0.02 | 0.05 | LogHF (ms2) | | | | | 0.82 | 0.05 | 0.07 | LogLF/HF | | | | | 0.42 | 0.19 | 0.60 | CysC (mg/l) | | | | | | | |
|
|
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; HbA1c: hemoglobin A1c; TC: total cholesterol; TG: triglyceride; HDL-C: HDL-cholesterol; LDL-C: LDL-cholesterol; Cr: creatinine; eGFR: estimated glomerular filtration rate; FBG: fasting blood glucose; UA: uric acid; β2-MG: β2-microglobulin; CysC: cystatin C.
|